CoChat

Nuclear actin structure regulates chromatin accessibility

Open access

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

Polymerized β-actin may provide a structural basis for chromatin accessibility and actin transport into the nucleus can guide mesenchymal stem cell (MSC) differentiation. Using MSC, we show that using CK666 to inhibit Arp2/3 directed secondary actin branching results in decreased nuclear actin structure, and significantly alters chromatin access measured with ATACseq at 24 h. The ATAC-seq results due to CK666 are distinct from those caused by cytochalasin D (CytoD), which enhances nuclear actin structure. In addition, nuclear visualization shows Arp2/3 inhibition decreases pericentric H3K9me3 marks. CytoD, alternatively, induces redistribution of H3K27me3 marks centrally. Such alterations in chromatin landscape are consistent with differential gene expression associated with distinctive differentiation patterns. Further, knockdown of the non-enzymatic monomeric actin binding protein, Arp4, leads to extensive chromatin unpacking, but only a modest increase in transcription, indicating an active role for actin-Arp4 in transcription. These data indicate that dynamic actin remodeling can regulate chromatin interactions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-024-48580-y

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Actin structure In the nucleus is altered by CK666 and CytoD. Mouse marrow-derived mesenchymal stem cell (MSC) were treated with CK666 (100 μM) or CytoD (0.1 μg/ml) for 4 h. A, B The cells were stained for Lamin A/C (red) and F-actin (green, phalloidin) and then examined using a model LSM 880 confocal microscope (Zeiss, Thornwood, NY) and (B) visualized using Airyscan. C Cells were transfected with the nuclear actin chromobody and imaged 4 h after treatment as specified. D The cells were stained for Arp3 (yellow, cy5), Lamin A/C (red) and F-actin (green, phalloidin). For images, a random cell in each of 6 HPF was selected for imaging, and representative image shown; scale bar: 25 μm. Imaging was performed in 3 separate experiments. E Nuclear G- and F-actin immunoblot analysis using G/F actin assay kit (Cytoskeleton, Inc.) for control, CK666 and Cyto D-treated MSCs. Data points represent mean densitometry ±SEM relative to vehicle-treated samples for n = 5 biologically independent samples; two way ANOVA with Sidak post-hoc adjusted for multiple comparison,; p = 0.0002 for CK666 and <0.0001 for CytoD. Source data are provided as a Source Data file.
Fig. 1 Actin structure In the nucleus is altered by CK666 and CytoD. Mouse marrow-derived mesenchymal stem cell (MSC) were treated with CK666 (100 μM) or CytoD (0.1 μg/ml) for 4 h. A, B The cells were stained for Lamin A/C (red) and F-actin (green, phalloidin) and then examined using a model LSM 880 confocal microscope (Zeiss, Thornwood, NY) and (B) visualized using Airyscan. C Cells were transfected with the nuclear actin chromobody and imaged 4 h after treatment as specified. D The cells were stained for Arp3 (yellow, cy5), Lamin A/C (red) and F-actin (green, phalloidin). For images, a random cell in each of 6 HPF was selected for imaging, and representative image shown; scale bar: 25 μm. Imaging was performed in 3 separate experiments. E Nuclear G- and F-actin immunoblot analysis using G/F actin assay kit (Cytoskeleton, Inc.) for control, CK666 and Cyto D-treated MSCs. Data points represent mean densitometry ±SEM relative to vehicle-treated samples for n = 5 biologically independent samples; two way ANOVA with Sidak post-hoc adjusted for multiple comparison,; p = 0.0002 for CK666 and <0.0001 for CytoD. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 Actin connections to nucleus are altered by CK666 and CytoD. A MSC were treated with CK666 or CytoD same as Fig. 1, and then stained focal adhesion (yellow, cy5), F-actin (green; phalloidin), and nucleus (blue; NucBlue). Images are representative of at least 3 biological repeats; scale bar: 25 μm. B Measurement of cell modulus, data for each condition acquired from 5 measures per each of 60 independent cells and presented as mean ± SEM; one way ANOVA with Tukey post hoc test adjusted for multiple comparisons; between group differences are shown as ****p < 0.0001, *p < 0.05. Source data are provided as a Source Data file.
Fig. 2 Actin connections to nucleus are altered by CK666 and CytoD. A MSC were treated with CK666 or CytoD same as Fig. 1, and then stained focal adhesion (yellow, cy5), F-actin (green; phalloidin), and nucleus (blue; NucBlue). Images are representative of at least 3 biological repeats; scale bar: 25 μm. B Measurement of cell modulus, data for each condition acquired from 5 measures per each of 60 independent cells and presented as mean ± SEM; one way ANOVA with Tukey post hoc test adjusted for multiple comparisons; between group differences are shown as ****p < 0.0001, *p < 0.05. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 Chromatin accessibility altered by CK666 and CytoD. A PCA shows CK666 (red) alters chromatin accessibility relatively more than CytoD (blue) when compared to the baseline control state (green). B Addition of CK666 results in more regions with significantly (p < 0.01; DESeq2 Wald test; adjusted using Benjamini-Hochberg correction) increased accessibility with greater magnitudes than regions with decreased accessibility. C Addition of CytoD results in more regions with significantly (p < 0.01; DESeq2 Wald test; adjusted using Benjamini-Hochberg correction) decreased accessibility. D Most chromatin changes are unique to a given condition (85% of CK666 regions; 81% of CytoD regions).
Fig. 3 Chromatin accessibility altered by CK666 and CytoD. A PCA shows CK666 (red) alters chromatin accessibility relatively more than CytoD (blue) when compared to the baseline control state (green). B Addition of CK666 results in more regions with significantly (p < 0.01; DESeq2 Wald test; adjusted using Benjamini-Hochberg correction) increased accessibility with greater magnitudes than regions with decreased accessibility. C Addition of CytoD results in more regions with significantly (p < 0.01; DESeq2 Wald test; adjusted using Benjamini-Hochberg correction) decreased accessibility. D Most chromatin changes are unique to a given condition (85% of CK666 regions; 81% of CytoD regions).CC BY · PubMed Central
Fig. 4 Gene expression altered relatively less than chromatin by CK666 and CytoD. A PCA shows CK666 (red) alters gene expression relatively more than CytoD (blue) when compared to the baseline control state (green), similar to chromatin accessibility. B Addition of CK666 results in similar numbers of genes with significantly (p < 0.01; DESeq2 Wald test; adjusted using Benjamini-Hochberg correction) increased and decreased expression and of similar magnitudes. C Addition of CytoD also results in similar numbers of genes with significantly (p < 0.01; DESeq2 Wald test; adjusted using Benjamini-Hochberg correction) increased and decreased expression, but with lower magnitudes than CK666. D The number of differentially expressed genes is less than altered chromatin regions, and relatively more are shared between conditions (24% of CK666 genes; 30% of CytoD genes). E Pathway enrichment for genes near differentially accessible chromatin (ATAC) and differentially expressed genes (RNA). Values are −log10 (adjusted p value of enrichment). See also Supplementary Fig. 1 which shows that CK666 induces adipogenesis at 3 days, while CytoD induces an osteoblast phenotype.
Fig. 4 Gene expression altered relatively less than chromatin by CK666 and CytoD. A PCA shows CK666 (red) alters gene expression relatively more than CytoD (blue) when compared to the baseline control state (green), similar to chromatin accessibility. B Addition of CK666 results in similar numbers of genes with significantly (p < 0.01; DESeq2 Wald test; adjusted using Benjamini-Hochberg correction) increased and decreased expression and of similar magnitudes. C Addition of CytoD also results in similar numbers of genes with significantly (p < 0.01; DESeq2 Wald test; adjusted using Benjamini-Hochberg correction) increased and decreased expression, but with lower magnitudes than CK666. D The number of differentially expressed genes is less than altered chromatin regions, and relatively more are shared between conditions (24% of CK666 genes; 30% of CytoD genes). E Pathway enrichment for genes near differentially accessible chromatin (ATAC) and differentially expressed genes (RNA). Values are −log10 (adjusted p value of enrichment). See also Supplementary Fig. 1 which shows that CK666 induces adipogenesis at 3 days, while CytoD induces an osteoblast phenotype.CC BY · PubMed Central
Fig. 5 Histone mark locations change with alterations in nuclear actin structure. The cells were treated with/without CK666 or CytoD for 4 h. A The cells stained for H3K9me3 and foci counted for heterochromatin called as “K9foci”, data for each condition was acquired from 50 independent cells and presented as mean ± SEM; one way ANOVA with Tukey post hoc test adjusted for multiple comparisons, between group differences are shown if p < 0.0001. B K9foci redistributed with CK666 to inner nuclear region; data acquired from 50 independent cells for each condition and presented as mean ± SEM, two-tailed t-test with p < 0.0001. C The cells were stained for H3K27me3. D H3K9me3 distribution in nucleus, data for each condition was acquired from 28 independent cells and presented as mean ± SEM; one way ANOVA with Tukey post hoc test adjusted for multiple comparisons, between group differences are shown if p < 0.0001. E Total H3K9me3 and H3K9me3 protein level was measured by Western blot; data points represent mean densitometry, relative to vehicle-treated samples for n = 3 biologically independent samples are presented as mean ± SEM, between group differences were not significant. Source data are provided as a Source Data file.
Fig. 5 Histone mark locations change with alterations in nuclear actin structure. The cells were treated with/without CK666 or CytoD for 4 h. A The cells stained for H3K9me3 and foci counted for heterochromatin called as “K9foci”, data for each condition was acquired from 50 independent cells and presented as mean ± SEM; one way ANOVA with Tukey post hoc test adjusted for multiple comparisons, between group differences are shown if p < 0.0001. B K9foci redistributed with CK666 to inner nuclear region; data acquired from 50 independent cells for each condition and presented as mean ± SEM, two-tailed t-test with p < 0.0001. C The cells were stained for H3K27me3. D H3K9me3 distribution in nucleus, data for each condition was acquired from 28 independent cells and presented as mean ± SEM; one way ANOVA with Tukey post hoc test adjusted for multiple comparisons, between group differences are shown if p < 0.0001. E Total H3K9me3 and H3K9me3 protein level was measured by Western blot; data points represent mean densitometry, relative to vehicle-treated samples for n = 3 biologically independent samples are presented as mean ± SEM, between group differences were not significant. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 6 Knockdown of Arp4 changes nuclear structure and prevents adipogenesis. The cells were stained for Arp4 (yellow, cy5), F-actin (green, phalloidin) and nucleus (blue; NucBlue). A The cells were treated with/without CK666 or CytoD for 4 h. B Arp4 was knocked-down and treated with/without CK666. For images (A, B), 6 HPF were imaged, and representative image shown; scale bar: 25 μm. Imaging was performed in 3 separate experiments. C K9foci counted; data for each condition was acquired from 28 independent cells and presented mean ± SEM; two way ANOVA with Tukey post hoc test adjusted for multiple comparisons shows group differences, ***p < 0.0001, **p = 0.003. D, E Arp4 was knocked-down and the cells treated with/without CK666 or A medium for 3 days. Western blot for Arp4, aP2 and Apn. Source data are provided as a Source Data file.
Fig. 6 Knockdown of Arp4 changes nuclear structure and prevents adipogenesis. The cells were stained for Arp4 (yellow, cy5), F-actin (green, phalloidin) and nucleus (blue; NucBlue). A The cells were treated with/without CK666 or CytoD for 4 h. B Arp4 was knocked-down and treated with/without CK666. For images (A, B), 6 HPF were imaged, and representative image shown; scale bar: 25 μm. Imaging was performed in 3 separate experiments. C K9foci counted; data for each condition was acquired from 28 independent cells and presented mean ± SEM; two way ANOVA with Tukey post hoc test adjusted for multiple comparisons shows group differences, ***p < 0.0001, **p = 0.003. D, E Arp4 was knocked-down and the cells treated with/without CK666 or A medium for 3 days. Western blot for Arp4, aP2 and Apn. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 7 Arp4 knockdown affects chromatin accessibility more than transcription. A PCA of ATAC-seq data (B, C) Volcano plots of ATAC-seq data (DESeq2 Wald test; p values adjusted using Benjamini-Hochberg correction) (D) Overlaps of ATAC-seq data (E) PCA of RNA-seq data (F, G) Volcano plots of RNA-seq data (DESeq2 Wald test; p values adjusted using Benjamini-Hochberg correction) (H) Overlaps of RNA-seq data (I) Combined pathway analysis.
Fig. 7 Arp4 knockdown affects chromatin accessibility more than transcription. A PCA of ATAC-seq data (B, C) Volcano plots of ATAC-seq data (DESeq2 Wald test; p values adjusted using Benjamini-Hochberg correction) (D) Overlaps of ATAC-seq data (E) PCA of RNA-seq data (F, G) Volcano plots of RNA-seq data (DESeq2 Wald test; p values adjusted using Benjamini-Hochberg correction) (H) Overlaps of RNA-seq data (I) Combined pathway analysis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 42

Metadata

Authors
Sen, B., Xie, Z., Thomas, M. D., Pattenden, S. G., Howard, S., McGrath, C., Styner, M., Uzer, G., Furey, T. S., & Rubin, J.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • Boise State University (US)
Corresponding author
Rubin, Janet
Venue
Nature Communications
Published
2024-05-15
Volume
15
Issue
1
Pages
4095-4095
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4396930035
Cited by
35
References
63
Citations by year
2026: 12 · 2025: 19 · 2024: 4
FWCI
4.75
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UNC Libraries
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR076803, AR073264)
  • U.S. Department of Health & Human Services | NIH | Center for Scientific Review (AG069923)
  • NSF | BIO | Division of Molecular and Cellular Biosciences (2025505)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
Keywords
nuclear actin, chromatin accessibility, Arp2/3 complex, cytochalasin D, Arp4, mesenchymal stem cell differentiation, H3K9me3, H3K27me3, actin cytoskeleton remodeling, transcriptional regulation, chromatin organization
MeSH terms
Actins, Animals, Cell Differentiation, Cell Nucleus, Chromatin, Histones, Humans, Microfilament Proteins, Cytochalasin D, Chromatin Assembly and Disassembly, Actin-Related Protein 2-3 Complex, Mice, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nuclear actin structure regulates chromatin accessibility. https://app.cochat.ai/papers/10.1038/s41467-024-48580-y
The paper
Sen, B., Xie, Z., Thomas, M. D., Pattenden, S. G., Howard, S., McGrath, C., Styner, M., Uzer, G., Furey, T. S., & Rubin, J. (2024). Nuclear actin structure regulates chromatin accessibility. Nature Communications. https://doi.org/10.1038/s41467-024-48580-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.